Long-term prognosis in patients with tachycardia-induced cardiomyopathy

Orlov, Oleg; Shchekochikhin, D. Yu.; Shchekochikhin, Dmitry; Akselrod, A.S.; Kauseva, O.I.; Андреев, Д. А.

doi:10.17116/kardio202215051508

Kardiol. serdechno-sosud. khir.

2022

DOI: 10.17116/kardio202215051508

|View full text |Cite

Long-term prognosis in patients with tachycardia-induced cardiomyopathy

Oleg Orlov¹,

D. Yu. Shchekochikhin²,

Dmitry Shchekochikhin³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Heart failure with improved ejection fraction in patients with tachycardia-induced cardiomyopathy: a case report

Pravkina,

Kochnova,

Pereverzeva

et al. 2023

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

Heart failure and arrhythmias are pathogenetically closely interconnected and they are mutually aggravating each other. At the same time, tachycardia-induced cardiomyopathy is particularly a reversible disease with proper treatment. This article presents a case report of an elderly patient with hypertension and atrial fibrillation, which are associated to an advanced heart failure and complicating the management of a decreasing kidneys filtration capacity, hematuria and brain stroke. In this case report, tachycardia-induced cardiomyopathy is caused by persistent atrial fibrillation. A complex approach to diagnosis and evidence-based treatment (in particular cardioversion and radiofrequency ablation) made it possible to restore sinus rhythm and compensate heart failure. Dynamics of the clinical state of the patient, laboratory indicators, echocardiographic characteristics allowed us to retrospectively verify atrial fibrillation-mediated cardiomyopathy as the main cause of heart failure progression, and classify this clinical case as heart failure with improved ejection fraction.

show abstract

Heart failure with improved ejection fraction in patients with tachycardia-induced cardiomyopathy: a case report

Pravkina,

Kochnova,

Pereverzeva

et al. 2023

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Long-term prognosis in patients with tachycardia-induced cardiomyopathy

Cited by 1 publication

References 22 publications

Heart failure with improved ejection fraction in patients with tachycardia-induced cardiomyopathy: a case report

Heart failure with improved ejection fraction in patients with tachycardia-induced cardiomyopathy: a case report

Contact Info

Product

Resources

About